Search results for “Lymph Cell” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,076 patents, we discovered top 404 key players by total patent application. Iovance Biotherapeutics, Inc., Pharmacyclics LLC, WindMIL Therapeutics, Inc. are dominant in this area. They take 15.06% of the total patent filing.
New York, United States
Patent: 107
California, United States
Patent: 31
STARTUP
New Jersey, United States
Patent: 24
Washington, United States
Patent: 22
Basel-Stadt, Switzerland
Patent: 21
Shanghai Shi, China
Patent: 20
California, United States
Patent: 19
Instil Bio (UK) Ltd.
United Kingdom
Patent: 19
STARTUP
United Kingdom
Patent: 16
Hessen, Germany
Patent: 13
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 67 patents, we discovered top 14 start-ups by total patent application. WindMIL Therapeutics, Inc., Gammadelta Therapeutics Ltd., Institut National de la Santé et de la Recherche Médicale are active in this area.
STARTUP
New Jersey, United States
Patent: 24
STARTUP
United Kingdom
Patent: 16
STARTUP
France
Patent: 11
California, United States
Patent: 3
STARTUP
Bayern, Germany
Patent: 3
STARTUP
Guangdong Sheng, China
Patent: 2
STARTUP
China
Patent: 1
STARTUP
Beijing Shi, China
Patent: 1
STARTUP
Jiangsu Sheng, China
Patent: 1
STARTUP
New York, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 932 patents applied in the last 5 years. We discover 394 most active companies in this area. The fast-growing Iovance Biotherapeutics, Inc., WindMIL Therapeutics, Inc., H. Lee Moffitt Cancer Center & Research Institute, Inc. take 16.20% of patent filing during this period.
New York, United States
Patent: 107
STARTUP
New Jersey, United States
Patent: 24
United States
Patent: 20
Instil Bio (UK) Ltd.
United Kingdom
Patent: 19
STARTUP
United Kingdom
Patent: 16
United States
Patent: 13
California, United States
Patent: 12
Australia
Patent: 12
California, United States
Patent: 12
Gyeonggi-do, South Korea
Patent: 10
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 932 patents in last 5 years, we discover 331 new entrants. Iovance Biotherapeutics, Inc., WindMIL Therapeutics, Inc., Instil Bio (UK) Ltd. are the most active new entrants in this area.
New York, United States
Patent: 107
STARTUP
New Jersey, United States
Patent: 24
Instil Bio (UK) Ltd.
United Kingdom
Patent: 19
STARTUP
United Kingdom
Patent: 16
Gyeonggi-do, South Korea
Patent: 10
Shanghai Shi, China
Patent: 9
Vaud, Switzerland
Patent: 6
North Carolina, United States
Patent: 6
Mingdao Innovation Medical Technology Co., Ltd
Beijing Shi, China
Patent: 5
Research Institutions
Order by:
Innovation Intensity
With the analysis among 409 patents, we discovered top 129 universities and scientific research institutions by total patent application. The Johns Hopkins University, University of Minnesota, University of South Florida are dominant in this area. They take 10.51% of the total patent filing.
United States
Patent: 21
Minnesota, United States
Patent: 11
United States
Patent: 7
North Carolina, United States
Patent: 7
North Carolina, United States
Patent: 6
North Carolina, United States
Patent: 5
Guangdong Sheng, China
Patent: 5
Zhejiang Sheng, China
Patent: 4
Groningen, Netherlands
Patent: 4
Connecticut, United States
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: